Everest Group Report: Redefining Pharma Engagement with AI

The Pharma industry is facing a pivotal challenge: while stakeholders like HCPs, KOLs, and patients expect personalised, connected experiences, siloed teams and fragmented data make each touchpoint feel disjointed. This report by Everest Group uncovers a new path forward, revealing how an AI-enabled platform can bridge these gaps to create seamless, end-to-end experiences across the entire value chain, from clinical trials to post-commercialisation.